ArticleCancers2022

Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer.

Valentina Danesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.